EPHB4 and neoplasm: The researchers developed an EPHB4-CAR-T cell (product name AP8901) that can specifically recognize and kill malignant tumor cells expressing the EPHB4 receptor by modifying ephrin B2, the natural ligand of the EPHB4 receptor (Figure 1).